Braster S.A. (WAR:BRA) — Market Cap & Net Worth
Market Cap & Net Worth: Braster S.A. (BRA)
Braster S.A. (WAR:BRA) has a market capitalization of $4.69 Million (zł17.04 Million) as of September 20, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #28807 globally and #330 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Braster S.A.'s stock price zł0.58 by its total outstanding shares 29383300 (29.38 Million). Also see total assets of Braster S.A. for a full breakdown of the balance sheet.
Braster S.A. Market Cap History: 2015 to 2025
Braster S.A.'s market capitalization history from 2015 to 2025. Data shows change from $107.96 Million to $4.69 Million (-26.99% CAGR). Also see Braster S.A. (BRA) cash flow conversion for how efficiently the company converts equity into cash flow.
Braster S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Braster S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BRA live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
14.70x
Braster S.A.'s market cap is 14.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.56 Million | $427.00K | -$14.39 Million | 340.89x | N/A |
| 2017 | $55.88 Million | $397.00K | -$24.89 Million | 140.75x | N/A |
| 2018 | $16.17 Million | $866.00K | -$19.78 Million | 18.68x | N/A |
| 2019 | $4.51 Million | $583.00K | -$15.54 Million | 7.74x | N/A |
| 2020 | $3.66 Million | $191.00K | -$15.99 Million | 19.14x | N/A |
| 2021 | $7.25 Million | $436.00K | -$9.11 Million | 16.62x | N/A |
| 2022 | $6.28 Million | $2.24 Million | -$3.91 Million | 2.81x | N/A |
| 2023 | $4.69 Million | $319.00K | -$4.75 Million | 14.70x | N/A |
Competitor Companies of BRA by Market Capitalization
Companies near Braster S.A. in the global market cap rankings as of September 20, 2026. Review how tangible is Braster S.A.'s equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Braster S.A. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Braster S.A. Historical Marketcap From 2015 to 2025
Between 2015 and today, Braster S.A.'s market cap moved from $107.96 Million to $ 4.69 Million, with a yearly change of -26.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | zł4.69 Million | 0.00% |
| 2024 | zł4.69 Million | 0.00% |
| 2023 | zł4.69 Million | -25.35% |
| 2022 | zł6.28 Million | -13.28% |
| 2021 | zł7.25 Million | +98.23% |
| 2020 | zł3.66 Million | -19.00% |
| 2019 | zł4.51 Million | -72.10% |
| 2018 | zł16.17 Million | -71.06% |
| 2017 | zł55.88 Million | -61.61% |
| 2016 | zł145.56 Million | +34.83% |
| 2015 | zł107.96 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Braster S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.69 Million USD |
| MoneyControl | $4.69 Million USD |
| MarketWatch | $4.69 Million USD |
| marketcap.company | $4.69 Million USD |
| Reuters | $4.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more